« Return to News | Awards & Advancement

PPD’s Dr. Ukwu named 2011 PharmaVOICE honoree

Tuesday, August 2, 2011 11:19 AM

PPD has reported that Dr. Henrietta Ukwu, senior vice president for global regulatory affairs, has been named to the 2011 PharmaVOICE 100 list of the most inspiring people in the life sciences industry.

The honor from PharmaVOICE magazine recognizes Dr. Ukwu's contributions in providing innovative leadership in the area of regulatory affairs in the endeavor of delivering life-changing medicines for people in need. An internist and infectious disease physician, Dr. Ukwu has extensive global regulatory experience across many biopharmaceutical therapeutic platforms and geographic regions. She was involved in numerous product development activities and directly led the successful original regulatory development and filings of 14 new products, all approved.

Dr. Ukwu captured the evolution of the life sciences industry and regulatory profession, as well as the crucial and strategic role of regulatory teams in fostering success, in her new book, Global Regulatory Systems: A Strategic Primer for Biopharmaceutical Product Development and Registration. The book, published by CenterWatch, is a comprehensive reference guide for navigating the complexities of regulatory systems for product development, approval and registration around the world.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.